State Of New Jersey Common Pension Fund D Chemo Centryx, Inc. Transaction History

State Of New Jersey Common Pension Fund D

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 28, 2022	BUY	$22.17 - $51.8 $1.06 Million - $2.48 Million	47,902 New	47,902 $2.48 Million
Q1 2022 May 03, 2022	SELL	$22.22 - $39.12 $1.58 Million - $2.77 Million	-70,925 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$18.38 - $40.5 $1.3 Million - $2.87 Million	70,925 New	70,925 $2.58 Million
Q2 2021 Jul 23, 2021	SELL	$9.59 - $50.88 $363,787 - $1.93 Million	-37,934 Closed	0 $0
Q1 2021 Apr 27, 2021	SELL	$49.53 - $68.4 $95,642 - $132,080	-1,931 Reduced 4.84%	37,934 $1.94 Million
Q4 2020 Feb 03, 2021	SELL	$47.25 - $65.16 $163,390 - $225,323	-3,458 Reduced 7.98%	39,865 $2.47 Million
Q3 2020 Oct 27, 2020	BUY	$46.35 - $61.69 $436,060 - $580,379	9,408 Added 27.74%	43,323 $2.37 Million
Q2 2020 Aug 04, 2020	BUY	$38.58 - $65.07 $1.31 Million - $2.21 Million	33,915 New	33,915 $1.95 Million

66.3K

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.